Research Topics
Species | Eva HerrmannSummaryAffiliation: Saarland University Country: Germany Publications
| Collaborators
|
Detail Information
Publications
Viral kinetics in patients with chronic hepatitis C treated with the serine protease inhibitor BILN 2061Eva Herrmann
Medizinische Klinik und Poliklinik, Innere Medizin II, Universitatsklinikum des Saarlandes, Homburg Saar, Germany
Antivir Ther 11:371-6. 2006..Estimates of viral clearance and infected-cell loss support conclusions on these rates and on treatment mechanisms from previous studies on interferon-alpha-based treatments...
Pharmacokinetics of peginterferonsStefan Zeuzem
Department of Medicine, Division of Gastroenterology, Hepatology, and Endocrinology, Saarland University Hospital, Homburg Saar, Germany
Semin Liver Dis 23:23-8. 2003..However, it remains unknown whether these differences in the initial viral decline predict differences in the primary clinical endpoint, sustained virological response...
The kinetics of hepatitis C virusEva Herrmann
Saarland University, Faculty of Medicine, Internal Medicine II, Homburg Saar, Germany
Eur J Gastroenterol Hepatol 18:339-42. 2006..The main aims of analysing hepatitis C viral kinetics include the efficient comparison of different treatment regimens, prediction of virological response, and conclusions on antiviral mechanisms of therapy...
Clinical significance of in vitro replication-enhancing mutations of the hepatitis C virus (HCV) replicon in patients with chronic HCV infectionChristoph Sarrazin
Klinik fur Innere Medizin II, Universitat des Saarlandes, Homburg Saar, Germany
J Infect Dis 192:1710-9. 2005..Mutations in nonstructural (NS) hepatitis C virus (HCV) proteins enhance replication in HCV-1a/b replicons. The prevalence of such mutations and their clinical significance in vivo are unknown...
Ultrasound evaluation of perihepatic lymph nodes during antiviral therapy with the protease inhibitor telaprevir (VX-950) in patients with chronic hepatitis C infectionMireen Friedrich Rust
Department of Internal Medicine, Saarland University Hospital, Homburg Saar, Germany
Ultrasound Med Biol 33:1362-7. 2007....
Dynamics of CD81 expression on lymphocyte subsets during interferon-alpha-based antiviral treatment of patients with chronic hepatitis CBernd Kronenberger
Klinik fur Innere Medizin II, Universitatsklinikum des Saarlandes, Kirrberger Strasse, D 66421 Homburg Saar, Germany
J Leukoc Biol 80:298-308. 2006..033). Lymphocyte subsets show different patterns of CD81 response before and during antiviral treatment, which are associated with administration of IFN-alpha and antiviral response...
Validity of N-terminal propeptide of the brain natriuretic peptide in predicting left ventricular diastolic dysfunction diagnosed by tissue Doppler imaging in patients with chronic liver diseaseTanja M Raedle-Hurst
Second Department of Medicine, Saarland University Hospital, Homburg Saar, Germany
Eur J Gastroenterol Hepatol 20:865-73. 2008..The aim of the study was to validate the N-terminal propeptide of the brain natriuretic peptide (NT-proBNP) in predicting left ventricular diastolic dysfunction diagnosed by tissue Doppler imaging in patients with chronic liver disease...
Growth differentiation factor 15--an early marker of abnormal function of the Fontan circuit in patients with univentricular heartsTanja M Raedle-Hurst
Department of Pediatric Cardiology, Saarland University Hospital, Homburg Saar, Germany
Am Heart J 160:1105-12. 2010..The aim of the study was to evaluate growth differentiation factor 15 (GDF-15), a marker of various stress pathways in the heart and extracardiac tissues...
Real-time elastography for noninvasive assessment of liver fibrosis in chronic viral hepatitisMireen Friedrich-Rust
Department of Internal Medicine II, Saarland University Hospital, Kirrbergerstrasse, Bldg 41, Homburg Saar 66421, Germany
AJR Am J Roentgenol 188:758-64. 2007..Here, we investigated a novel approach for noninvasive assessment of liver fibrosis using sonography-based real-time elastography, which can be performed with conventional ultrasound probes during a routine sonography examination...
Assessment of left ventricular dyssynchrony and function using real-time 3-dimensional echocardiography in patients with congenital right heart diseaseTanja M Raedle-Hurst
Department of Pediatric Cardiology, Saarland University Hospital, Homburg Saar, Germany
Am Heart J 157:791-8. 2009..The aim of the study was to assess LVD according to a novel global systolic dyssynchrony index (SDI) derived from real-time 3-dimensional echocardiography in patients after repaired CRHD...
Structural and functional comparison of the non-structural protein 4B in flaviviridaeChristoph Welsch
Internal Medicine II, Saarland University Hospital, Kirrberger Strasse, 66421 Homburg Saar, Germany
J Mol Graph Model 26:546-57. 2007..Important structural and functional properties of NS4B are predicted with implications for ER-stress response, altered gene expression and replication efficacy...
Effect of ribavirin on hepatitis C viral kinetics in patients treated with pegylated interferonEva Herrmann
Medizinische Klinik und Poliklinik, Innere Medizin II, , Homburg/Saar, Germany
Hepatology 37:1351-8. 2003..This finding suggests that combination treatment leads to a better restoration of the patient's immune response...
Hepatitis C virus nonstructural 5A protein and interferon resistance: a new model for testing the reliability of mutational analysesChristoph Sarrazin
Medizinische Klinik II, Johann Wolfgang Goethe Universitat, 60590 Frankfurt am Main, Germany
J Virol 76:11079-90. 2002..For improvement of mutational analysis, a refined specific functional data test procedure is proposed...
Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapyThomas Berg
Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie, , Campus Virchow-Klinikum, , Berlin, Germany
Hepatology 37:600-9. 2003..This algorithm recognizes 53.7% of nonresponders previously identified at week 24 of treatment...
Hepatitis C viral kinetics in plasma and peripheral blood mononuclear cells during pegylated interferon-alpha2a/ribavirin therapyPaolo Pugnale
Department of Pathology and Immunology, University of Geneva Medical Center, 1211 Geneva, Switzerland
J Hepatol 48:932-8. 2008..Analysis of hepatitis C virus (HCV) RNA kinetics in compartments other than plasma may help in understanding HCV replication and identifying clinically significant patterns of treatment response...
Dynamics of apoptotic activity during antiviral treatment of patients with chronic hepatitis CBernd Kronenberger
Medizinische Klinik I, Klinikum der Johann Wolfgang Goethe UniversitRt, Frankfurt Main, Germany
Antivir Ther 12:779-87. 2007..Cell death during antiviral therapy of patients with chronic hepatitis C is not well understood...
Impact of NS5A sequences of Hepatitis C virus genotype 1a on early viral kinetics during treatment with peginterferon- alpha 2a plus ribavirinFrancesca Dal Pero
Venetian Institute for Molecular Medicine, Padova, 35129, Italy
J Infect Dis 196:998-1005. 2007..Little is known about NS5A sequences of HCV-1a. We investigated whether genetic variability of HCV-1a NS5A correlates with the early HCV kinetics during treatment...
Reply to Real-time elastography in the assessment of liver fibrosisMireen Friedrich-Rust
AJR Am J Roentgenol 190:W164. 2008
Amino acid variations in hepatitis C virus p7 and sensitivity to antiviral combination therapy with amantadine in chronic hepatitis CUlrike Mihm
, , Kirrberger Str, 66421 Homburg/Saar, Germany
Antivir Ther 11:507-19. 2006..Non-responders with HCV-1b infection showed higher numbers of non-conservative aa variations within HCV p7 than responders, irrespective of the application of amantadine...
Mutagenic effect of ribavirin on hepatitis C nonstructural 5B quasispecies in vitro and during antiviral therapyWolf Peter Hofmann
Department of Internal Medicine II, Saarland University Hospital, Homburg, Germany
Gastroenterology 132:921-30. 2007..Ribavirin acts as an RNA virus mutagen in vitro, thereby leading to error catastrophe. However, data in CHC are controversial...
Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: a placebo-controlled trialThomas Berg
Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie, Universitatsklinikum Charite, Campus Virchow Klinikum, Humboldt Universitat, Berlin, Germany
Hepatology 37:1359-67. 2003....
Viral kinetics during antiviral therapy in patients with chronic hepatitis C and persistently normal ALT levelsBernd Kronenberger
, , Homburg/Saar, Germany
Hepatology 40:1442-9. 2004..These data show that virological response in patients with chronic hepatitis C is less associated with baseline ALT than with GGT levels...
Comparison of transcription mediated amplification (TMA) and reverse transcription polymerase chain reaction (RT-PCR) for detection of hepatitis C virus RNA in liver tissueWolf Peter Hofmann
, , 66421 Homburg, Germany
J Clin Virol 32:289-93. 2005..019). CONCLUSION: Our results suggest that both the extraction and amplification step of the TMA-based assay contribute to the higher sensitivity compared with standard RT-PCR...
Peginterferon-alpha-2a (40KD) and ribavirin for 16 or 24 weeks in patients with genotype 2 or 3 chronic hepatitis CMichael von Wagner
, Homburg/Saar, Germany
Gastroenterology 129:522-7. 2005..In patients infected by HCV-3 (high viral load), longer treatment may be necessary...
Relationship between early HCV kinetics and T-cell reactivity in chronic hepatitis C genotype 1 during peginterferon and ribavirin therapyKwok H Tang
Institute of Hepatology, University College London, 69-75 Chenies Mews, London. WC1E 6HX, UK
J Hepatol 43:776-82. 2005..Enhancement of antiviral T-cell reactivity requires rapid viraemia clearance, rather than immunostimulation alone...
New kinetic models for the hepatitis C virusAlan S Perelson
Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM 87525, USA
Hepatology 42:749-54. 2005....
Dynamics of hepatitis C virus infectionStefan Zeuzem
Department of Medicine, University Hospital Homburg/Saar, Germany
Ann Hepatol 1:56-63. 2002..This second phase decay is predictive for the virologic end-of-treatment and even more the sustained response. Non-responding patients typically show constant viremia or even a rebound during this second phase...
Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: a randomized open-label pilot studyMarkus Cornberg
Abt. Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule Hannover, Hannover, Germany
J Hepatol 44:291-301. 2006..However, motivation and compliance are requisites and a CIFN induction is not required...
Association of serum interleukin-8 with virologic response to antiviral therapy in patients with chronic hepatitis CUlrike Mihm
, , Kirrberger Strasse, D-66421 Homburg/Saar, Germany
J Hepatol 40:845-52. 2004..Thus, the conclusion from in vitro studies that the upregulation of interleukin-8 by the hepatitis C virus contributes to the inhibition of the antiviral actions of interferon-alpha may also be applicable in vivo...
Placebo-controlled trial of 400 mg amantadine combined with peginterferon alfa-2a and ribavirin for 48 weeks in chronic hepatitis C virus-1 infectionMichael von Wagner
Johann Wolfgang Goethe Universitat, Frankfurt, Main, Germany
Hepatology 48:1404-11. 2008..CONCLUSION: In this large placebo-controlled multicenter study, amantadine even at a dose of 400 mg/day did not improve virological response rates of peginterferon alfa-2a and ribavirin in patients with chronic genotype HCV-1 infection...
Performance of transient elastography for the staging of liver fibrosis: a meta-analysisMireen Friedrich-Rust
Department of Internal Medicine I, J W Goethe University Hospital, Frankfurt, Germany
Gastroenterology 134:960-74. 2008..A meta-analysis was performed to assess the overall performance of transient elastography for the diagnosis of liver fibrosis and to analyze factors influencing the diagnostic accuracy...
Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical fibrosis markersMireen Friedrich-Rust
Department of Internal Medicine, JW Goethe University Clinic, Frankfurt, Germany
J Thorac Cardiovasc Surg 135:560-7. 2008..Therefore, early detection of fibrosis is essential to identify patients at risk. Transient elastography has been evaluated for noninvasive staging of liver fibrosis in a multitude of studies...
Modelling of early viral kinetics and pegylated interferon-alpha2b pharmacokinetics in patients with HBeag-positive chronic hepatitis BMartijn J ter Borg
Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands
Antivir Ther 12:1285-94. 2007..HBeAg loss is achieved in 36% of patients after one year of PEG-IFN-alpha2b treatment and combination therapy with lamivudine is not superior to PEG-IFN-alpha2b monotherapy...
Efficacy of amantadine on quality of life in patients with chronic hepatitis C treated with interferon-alpha and ribavirin: results from a randomized, placebo-controlled, double-blind trialBernd Kronenberger
Department of Medicine I, Johann Wolfgang Goethe University Medical Center, Frankfurt M, Germany
Eur J Gastroenterol Hepatol 19:639-46. 2007..The aim of this study was to investigate whether amantadine reduces deterioration of quality of life in patients with chronic hepatitis C during and after treatment with interferon-alpha (IFN-alpha) and ribavirin...
Association of HCV-related mixed cryoglobulinemia with specific mutational pattern of the HCV E2 protein and CD81 expression on peripheral B lymphocytesWolf Peter Hofmann
Blood 104:1228-9. 2004
The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cellsGeorge Koutsoudakis
Department Molecular Virology, University Heidelberg, Im Neuenheimer Feld 345, 69120 Heidelberg, Germany
J Virol 81:588-98. 2007..Together these data indicate that a high density of cell surface-exposed CD81 is a key determinant for productive HCV entry into host cells...
Viral kinetics in patients with lamivudine-resistant hepatitis B during adefovir-lamivudine combination therapyUlrike Mihm
, , Kirrberger Str, 66421 Homburg/Saar, Germany
J Hepatol 43:217-24. 2005....
First-phase parameters in hepatitis C viral kineticsStefan Zeuzem
Department of Medicine, Division of Gastroenterology, Hepatology, and Endocrinology, University Hospital Homburg/Saar, Germany
J Viral Hepat 9:332-3. 2002
